 Biomerica, Inc. BMRA today reported net sales of 3,967,712 for the nine months ending February 29, 2020, compared to 4,034,822 for the period ended February 28, 2019. For the nine months ended February 29, 2020, the Company reported a net loss of 1,852,482 compared to net loss of 1,607,730 for the nine months in the previous fiscal year. Since the Companys third quarter ended February 29, 2020, the above results do not include any revenues or expenses associated with the Company announcements of March 17, 2020, and April 2, 2020 relating to the Companys SARS CoV-2 COVID-19 serology IgGIgM rapid antibody test and its ELISA serology IgGIgMIgA high-volume open system lab scale test. 